v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Pre-Funded Warrants
Common Stock
Common Stock
Pre-Funded Warrants
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     73,977,459      
Beginning balance at Dec. 31, 2024 $ 9,465   $ 7   $ 257,583 $ (248,125)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs (in shares)     8,200,000      
Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs 23,051   $ 1   23,050  
Issuance of common stock upon the exercise of warrants (in shares)     669,233 8,000,000    
Issuance of common stock upon the exercise of warrants 502 $ 1   $ 1 502  
Issuance of common stock under employee stock purchase plan (in shares)     49,433      
Issuance of common stock under employee stock purchase plan 48       48  
Stock-based compensation 505       505  
Net loss (5,813)         (5,813)
Ending balance (in shares) at Mar. 31, 2025     90,896,125      
Ending balance at Mar. 31, 2025 $ 27,759   $ 9   281,688 (253,938)
Beginning balance (in shares) at Dec. 31, 2025 153,103,459   153,103,459      
Beginning balance at Dec. 31, 2025 $ 70,871   $ 15   345,844 (274,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon the exercise of warrants (in shares)     28,183,265      
Issuance of common stock upon the exercise of warrants 44,084   $ 3   44,081  
Issuance of common stock under employee stock purchase plan (in shares)     45,850      
Issuance of common stock under employee stock purchase plan 66       66  
Stock-based compensation 798       798  
Net loss $ (8,407)         (8,407)
Ending balance (in shares) at Mar. 31, 2026 181,332,574   181,332,574      
Ending balance at Mar. 31, 2026 $ 107,412   $ 18   $ 390,789 $ (283,395)